Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2018 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

2 results

Results by year

Filters applied: . Clear all
Unknown field was ignored: [18F]
Page 1
Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment: The Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Study.
Boccardi M, Altomare D, Ferrari C, Festari C, Guerra UP, Paghera B, Pizzocaro C, Lussignoli G, Geroldi C, Zanetti O, Cotelli MS, Turla M, Borroni B, Rozzini L, Mirabile D, Defanti C, Gennuso M, Prelle A, Gentile S, Morandi A, Vollaro S, Volta GD, Bianchetti A, Conti MZ, Cappuccio M, Carbone P, Bellandi D, Abruzzi L, Bettoni L, Villani D, Raimondi MC, Lanari A, Ciccone A, Facchi E, Di Fazio I, Rozzini R, Boffelli S, Manzoni L, Salvi GP, Cavaliere S, Belotti G, Avanzi S, Pasqualetti P, Muscio C, Padovani A, Frisoni GB; Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Working Group. Boccardi M, et al. JAMA Neurol. 2016 Dec 1;73(12):1417-1424. doi: 10.1001/jamaneurol.2016.3751. JAMA Neurol. 2016. PMID: 27802513
OBJECTIVE: To evaluate the incremental diagnostic value of amyloid PET with florbetapir F 18 in addition to the routine clinical diagnostic assessment of patients evaluated for cognitive impairment. ...Diagnostic confidence in AD …
OBJECTIVE: To evaluate the incremental diagnostic value of amyloid PET with florbetapir F 18 in addition …
Quantitative appraisal of the Amyloid Imaging Taskforce appropriate use criteria for amyloid-PET.
Altomare D, Ferrari C, Festari C, Guerra UP, Muscio C, Padovani A, Frisoni GB, Boccardi M; Incremental Diagnostic Value of Amyloid PET With [(18)F]-Florbetapir (INDIA-FBP) Working Group. Altomare D, et al. Alzheimers Dement. 2018 Aug;14(8):1088-1098. doi: 10.1016/j.jalz.2018.02.022. Epub 2018 Apr 19. Alzheimers Dement. 2018. PMID: 29679576
INTRODUCTION: We test the hypothesis that amyloid-positron emission tomography prescriptions, considered appropriate based on the Amyloid Imaging Taskforce (AIT) criteria, lead to greater clinical utility than AIT-inappropriate prescriptions. METHODS: We compared th …
INTRODUCTION: We test the hypothesis that amyloid-positron emission tomography prescriptions, considered appropriate based on the …